KR100311679B1 - Water in silicon type make-up cosmetic composition with whitening function - Google Patents
Water in silicon type make-up cosmetic composition with whitening function Download PDFInfo
- Publication number
- KR100311679B1 KR100311679B1 KR1019990012097A KR19990012097A KR100311679B1 KR 100311679 B1 KR100311679 B1 KR 100311679B1 KR 1019990012097 A KR1019990012097 A KR 1019990012097A KR 19990012097 A KR19990012097 A KR 19990012097A KR 100311679 B1 KR100311679 B1 KR 100311679B1
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- weight
- whitening
- water
- skin
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 100
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 229910052710 silicon Inorganic materials 0.000 title claims abstract description 4
- 239000010703 silicon Substances 0.000 title claims abstract description 4
- 230000002087 whitening effect Effects 0.000 title abstract description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract description 14
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 title description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims abstract description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 22
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims abstract description 20
- 229940086555 cyclomethicone Drugs 0.000 claims abstract description 19
- 229940008099 dimethicone Drugs 0.000 claims abstract description 15
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims abstract description 15
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 15
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 15
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 claims abstract description 12
- 239000004137 magnesium phosphate Substances 0.000 claims abstract description 12
- 229960002261 magnesium phosphate Drugs 0.000 claims abstract description 12
- 229910000157 magnesium phosphate Inorganic materials 0.000 claims abstract description 12
- 235000010994 magnesium phosphates Nutrition 0.000 claims abstract description 12
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 11
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 11
- 239000011718 vitamin C Substances 0.000 claims abstract description 11
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 10
- 229960000271 arbutin Drugs 0.000 claims abstract description 10
- 239000006185 dispersion Substances 0.000 claims abstract description 10
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 10
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 10
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 8
- 239000000839 emulsion Substances 0.000 claims description 13
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 3
- 229960003237 betaine Drugs 0.000 claims description 3
- 229940085262 cetyl dimethicone Drugs 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims 2
- DJFBJKSMACBYBD-UHFFFAOYSA-N phosphane;hydrate Chemical compound O.P DJFBJKSMACBYBD-UHFFFAOYSA-N 0.000 claims 1
- 230000003020 moisturizing effect Effects 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- 208000003251 Pruritus Diseases 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 5
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract description 4
- 210000003491 skin Anatomy 0.000 description 30
- 239000002994 raw material Substances 0.000 description 11
- 102000003425 Tyrosinase Human genes 0.000 description 8
- 108060008724 Tyrosinase Proteins 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000000638 stimulation Effects 0.000 description 7
- 238000002845 discoloration Methods 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007596 consolidation process Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- -1 Polyoxyethylene Polymers 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 미백원료인 알부틴과 비타민C 마그네슘 포스페이트를 다량 함유하여 미백효과가 우수하면서 피부보습 효과 및 안정도가 우수한 워터 인 실리콘(WATER IN SILICON:W/S) 유형의 메이컵 화장료 조성물에 관한 것으로 알부틴 1 ~ 3중량%, 비타민 C 마그네슘 포스페이트 0.5 ~ 2중량% 등 화장료 조성물에 사이클로메치콘(D5) 4 ~ 17중량%, 사이클로메치콘(D6) 5 ~ 8중량%, 히아루론산 0.01 ~ 0.05중량%, C30 ~ 45알킬메치콘 0.1 ~ 4.0중량%, 스테아릴디메치콘 1 ~ 4중량% 추가로 더 포함하여 워터 인 실리콘(W/S) 유형의 분산, 유화상 메이컵 화장료 조성물로서 미백기능 및 스킨케어기능이 우수하고 피부소양증이 없으며 수적 합일이나 점도저하가 없는 뛰어난 효과가 있다.The present invention relates to a make-up cosmetic composition of a water in silicone (WATER IN SILICON: W / S) type having excellent whitening effect and excellent skin moisturizing effect by containing a large amount of arbutin and vitamin C magnesium phosphate as a whitening material. 1 to 3% by weight, vitamin C magnesium phosphate 0.5 to 2% by weight of cyclomethicone (D5) 4 to 17% by weight, cyclomethicone (D6) 5 to 8% by weight, hyaluronic acid 0.01 to 0.05% by weight, C 30 ~ 45 Alkylmethicone 0.1 ~ 4.0% by weight, stearyl dimethicone 1 ~ 4% by weight of further including water-in-silicone (W / S) type of dispersion, emulsified makeup cosmetic composition as a whitening function and skin It has excellent care function, no skin pruritus, and excellent effect with no water drop or viscosity decrease.
Description
본 발명은 미백 기능이 있는 워터 인 실리콘(WATER IN SILICON; 이하 'W/S'라 함)유형 메이컵 화장료 조성물에 관한 것이다. 더욱 상세하게는, 본 발명은 미백원료인 알부틴과 비타민 C 마그네슘 포스페이트를 다량 함유하여 미백효과가 우수하면서도 피부보습 효과 및 안정도가 우수한 W/S 유형의 메이컵 화장료 조성물에 관한 것이다.The present invention relates to a water-in-silicone (WATER IN SILICON) type makeup cosmetic composition having a whitening function. More specifically, the present invention relates to a makeup cosmetic composition of the W / S type having a high whitening effect and excellent skin moisturizing effect and stability by containing a large amount of arbutin and vitamin C magnesium phosphate as a whitening material.
피부가 자외선에 노출되면 피부를 보호하고자 천연자외선차단제인 멜라닌세포가 피부내에서 생성되고 이러한 멜라닌세포는 사람의 피부색을 좌우하며, 백인종보다는 황인종, 흑인종이 멜라닌 세포가 많아 피부색이 검게 보이며, 자외선에 의한 피부암 발생빈도도 백인종이 많이 생기는 것은 익히 알려져 있는 사실이다. 그러나, 멜라닌의 과침착으로 인하여 기미, 주근깨 및 피부흑화가 발생한다. 따라서, 일소에 의한 피부흑화방지 및 기생성된 멜라닌 세포를 환원시키고자 미백원료가 함유된 화장품의 개발이 요구되고 있다.When the skin is exposed to ultraviolet rays, melanocytes, which are natural UV blockers, are produced in the skin to protect the skin.These melanocytes influence the color of the human skin, and the skin color is black because there are more yellow melanoma and black species than melanoma. The frequency of skin cancer caused by a lot of white people is a well known fact. However, overdeposition of melanin causes melasma, freckles, and skin darkening. Therefore, there is a need for the development of a cosmetic containing a whitening raw material to prevent skin darkening caused by sunburn and to reduce parasitic melanocytes.
일반적으로 분산, 유화 유형의 메이컵화장료의 경우 소비자 사용시 먼저 기초제품(스킨, 로션, 크림, 에센스 등)을 사용한 후에 베이스 메이컵의 단계에서 사용하게 되는데 이러한 화장 단계는 대단히 번거롭고 비용 및 시간상의 손실이 크며 미백기능은 별도의 기능성 스킨케어제품을 통하여 얻어야만 하였다. 하지만 종래의 분산, 유화제품들의 경우 이러한 미백 및 스킨케어적인 면이 부족하였고 또한 미백 및 스킨케어적인 면을 강조하는 제품들도 미백기능의 일부 고가원료들을 소량 함유하므로써 그 효과를 명확히 나타내지 못했다. 즉, 알부틴, 플라센타추출물, 코직산, 최근에는 라이온의 에락산, 폴라의 루시놀 등이 미백 원료로 개발되었고 이들 미백원료들은 주로 티로시나제의 활성을 억제하여 멜라닌 생성의 근본원인을 차단하지만 제품에 극히 제한적으로 첨가되며 자체의 활성 때문에 제품의 안정도가 저하되고 변색이 발생하며 피부에 직접 접촉시 피부 소양증 등을 야기시키는 문제점이 있다. 따라서, 상기 문제점을 해결하고자 미백원료를 소구체화하여 피부에 직접적으로 접촉하는 것을 피하는 한편, 미백기능의 활성도 유지와 서방성을 줄 수 있도록 W/O형 에멀젼이 개발되었다. 그러나 이 경우, 첫째로 외상이 오일인 관계로 사용감이 뻑뻑하고 답답하였으며 두번째로 화장품에 사용되는 일반적인 에멀젼 형태인 O/W 에멀젼에 비해 오일이 스며나오거나 수적의 합일 등이 발생하므로써 제형의 안정화가 미흡하여 제품화하기에는 제한적이였으며 특히 미백원료의 함유로 점도의 저하와 수적의 합일을 촉진시켜 제품의 제형유지가 곤란하였다.In general, in the case of disperse and emulsified makeup cosmetics, the basic product (skin, lotion, cream, essence, etc.) is used in the stage of the base makeup after consumer use. This large, whitening function had to be obtained through a separate functional skincare product. However, in the case of the conventional dispersion and emulsified products, such whitening and skin care aspects are lacking, and the products that emphasize the whitening and skin care aspects also do not show the effect by containing a small amount of some expensive raw materials of the whitening function. In other words, arbutin, placenta extract, kojic acid, lion's eractic acid, and polar's rucinol have been developed as whitening raw materials, and these whitening raw materials mainly inhibit the activity of tyrosinase to block the root cause of melanin production, but the products are extremely limited. Due to its activity, the stability of the product is lowered due to its activity, discoloration occurs, and there is a problem of causing skin pruritus and the like in direct contact with the skin. Therefore, in order to solve the above problems, W / O emulsions have been developed so that the whitening raw material can be spheroidized to avoid direct contact with the skin, while maintaining the activity and sustained release of the whitening function. However, in this case, the use of the oil is soaked and stuffy due to the fact that the trauma is oil, and secondly, the oil oozes out or the condensation of water droplets occurs compared to the general emulsion type O / W emulsion used in cosmetics. Insufficient product was limited and it was difficult to maintain the formulation of the product, especially by the inclusion of whitening raw materials, promoting the reduction of viscosity and the integration of water droplets.
따라서 상기 문제점을 해결하고자 본 발명자들은 소구체화한 미백원료를 함유하면서 기존의 W/O 유형에서 사용하던 오일 대신 실리콘 오일을 사용한 W/S 유형 에멀젼에 사이클로메치콘(D5 및 D6) 및 C30 ~ 45알킬디메치콘, 스테아릴디메치콘, 히아루론산을 더 첨가하여 미백 효과 및 피부보습 효과가 있고 피부소양증이 없으며 수적 합일이나 점도저하가 발생하지 않는 안정한 화장료 조성물을 제조하므로써 본 발명을 완성하였다.Therefore, in order to solve the above problems, the present inventors have disclosed cyclomethicone (D5 and D6) and C 30 to W / S type emulsions using silicone oils instead of oils used in conventional W / O types while containing small-sized whitening raw materials. By adding 45 alkyldimethicone, stearyldimethicone, and hyaluronic acid, the present invention was completed by preparing a stable cosmetic composition having a whitening effect and a skin moisturizing effect, no skin pruritus, and no water consolidation or viscosity decrease.
본 발명의 목적은 미백원료로 소구체화한 알부틴과 비타민 C 마그네슘 포스페이트, 안정화제로 C30 ~ 45알킬디메치콘, 스테아릴디메치콘 및 보습제로 히아루론산을 더 함유하므로써 미백효과와 피부보습 효과가 우수하고 피부소양증이 없으며 수적 합일이나 점도저하가 없는 안정한 W/S 유형 메이컵 화장료 조성물을 제공함에 있다.The purpose of the present invention is to further contain the whitening effect and skin moisturizing effect by further containing hyaluronic acid as arbutin and vitamin C magnesium phosphate stabilizer as a whitening raw material, C 30 ~ 45 alkyldimethicone as a stabilizer, stearyl dimethicone and a moisturizing agent The present invention provides a stable W / S type makeup cosmetic composition that is free of pruritus and has no water soaking or viscosity decrease.
본 발명의 상기 목적은 미백원료를 함유하는 종래의 O/W 유중수적화 유형의 화장료 조성물과 본 발명의 W/S 유형의 화장료 조성물을 제조한 후 피부자극도와 보습효과, 미백효과 및 소비자 만족도를 각각 조사한 다음 사이클로메치콘과 C30 ~ 45알킬메치콘, 스테아릴디메치콘 및 히아루론산을 함유하지 않는 종래 화장료 조성물과 이들 성분을 더 함유하는 본 발명 화장료 조성물을 제조한 후 안정도와 점도변화를 조사하므로써 달성하였다.The object of the present invention is to prepare a cosmetic composition of the conventional O / W water-in-oil type and a cosmetic composition of the W / S type of the present invention containing a whitening raw material, the skin stimulation and moisturizing effect, whitening effect and customer satisfaction After investigating each of them, the conventional cosmetic composition containing no cyclomethicone, C 30-45 alkylmethicone, stearyldimethicone, and hyaluronic acid and the present cosmetic composition further containing these components were prepared by investigating stability and viscosity change. Achieved.
본 발명은 미백원료로 알부틴과 비타민 C 마그네슘 포스페이트를 함유하는 O/W 유중수적화 유형의 종래 미백 화장료 조성물과 본 발명 W/S 유형의 미백 화장료 조성물을 제조하는 단계; 상기 제조된 종래 및 본 발명 화장료 조성물의 피부 보습력과 피부자극도를 조사하는 단계; 역시 상기 제조된 종래 및 본 발명 화장료 조성물의 미백효과를 티로시나제 활성억제효과를 측정하여 조사하는 단계; 역시 상기 제조된 종래 및 본 발명 화장료 조성물의 소비자 만족도를 조사하는 단계; 미백 원료와 함께 사이클로메치콘(D5 또는 D6), C30 ~ 45알킬디메치콘, 스테아릴디메치콘을 더 함유하는 본 발명 분산 유화 메이컵 화장료 조성물과 미백 원료는 함유하나 상기 사이클로메치콘(D5 또는 D6), C30 ~ 45알킬디메치콘, 스테아릴디메치콘 성분을 함유하지 않는 종래 미백 화장료 조성물을 제조하는 단계 및; 상기 제조된 본 발명 분산 유화 메이컵 화장료 조성물과 종래 미백 화장료 조성물의 점도 변화와 변색을 관찰하여 안정도를 각각 측정하는 단계로 구성된다.본 발명에서 사이클로메치콘 D5 또는 D6는 환형실리콘의 구조에 따른 구별로서 전자는 5각 구조를, 후자는 6각 구조를 이루고 있는 것으로 각각 상품명 DC345(Dow Corning) 및 DC246(Dow Corning)이 있다. 또, 본 발명에서 C30 ~ 45알킬디메치콘은 디메치콘의 구조에 탄소수 30∼45개인 알킬기가 붙어있는 것을 사용하고 왁스상의 물질이며, 비타민 C 마그네슘포스페이트는 산화안정성이 높은 물질로서 비타민 C에 마그네슘포스페이트가 결합된 원료이며 상품명 'VC-PMG'(Nikkol)을 사용한다. 또, 본 발명의 실시예에서 사이클로메치콘과 디메치콘 코폴리올을 동시에 사용하는 바 이는 점성이 높은 유화제인 디메치콘코폴리올을 사이클로메치콘이라는 기재(基材)에 분산시켜 디메치콘 코폴리올의 분산성을 증진하기 위한 것이며,상품명 'DC5225-C(Dow Corning)'을 원료로 사용하였다.The present invention comprises the steps of preparing a whitening cosmetic composition of the O / W water-in-oil-integrated type and whitening cosmetic composition of the present invention W / S type containing arbutin and vitamin C magnesium phosphate as a whitening material; Investigating the skin moisturizing power and skin irritation of the prepared conventional and the present invention cosmetic composition; Investigating the whitening effect of the conventional and the present invention cosmetic composition prepared by measuring the tyrosinase activity inhibitory effect; Investigating the customer satisfaction of the conventional and the present invention cosmetic composition prepared; The present invention also contains a cyclomethicone (D5 or D6), a C 30-45 alkyldimethicone, a stearyldimethicone, and a dispersion emulsion makeup cosmetic composition and a whitening material. D6), preparing a conventional whitening cosmetic composition containing no C 30-45 alkyldimethicone, stearyldimethicone component; Observing the change in viscosity and discoloration of the prepared dispersion-emulsion makeup cosmetic composition and the conventional whitening cosmetic composition of the present invention is composed of the step of measuring the stability respectively. In the present invention cyclomethicone D5 or D6 according to the structure of the cyclic silicone As a distinction, the former has a pentagonal structure and the latter has a hexagonal structure, and there are trade names DC345 (Dow Corning) and DC246 (Dow Corning), respectively. In the present invention, C 30 to 45 alkyl dimethicone is a waxy substance that uses an alkyl group having 30 to 45 carbon atoms attached to the structure of dimethicone, and vitamin C magnesium phosphate is a substance having high oxidation stability and magnesium Phosphate is a combined raw material and uses the trade name 'VC-PMG' (Nikkol). In the embodiment of the present invention, the cyclomethicone and dimethicone copolyols are used simultaneously. This is because the dimethicone copolyol, which is a highly viscous emulsifier, is dispersed in a base material called cyclomethicone to separate the dimethicone copolyol. To enhance the acidity, the brand name 'DC5225-C (Dow Corning)' was used as a raw material.
이하 본 발명의 구체적인 방법을 실시예와 실험예를 들어 상세히 설명하고자 하지만 본 발명의 권리범위는 이들 실시예와 실험예에만 한정되는 것은 아니다.Hereinafter, the specific method of the present invention will be described in detail with reference to Examples and Experimental Examples, but the scope of the present invention is not limited to these Examples and Experimental Examples.
실시예 1: 본 발명 W/S 화장료 조성물 및 종래 O/W 화장료 조성물 제조Example 1: Preparation of the present invention W / S cosmetic composition and conventional O / W cosmetic composition
본 실시예에서는 하기 표 1에 나타나 있는 성분 및 성분비(중량%)로 분산,유화 메이컵 화장료 조성물을 유상과 수상을 분리한 후에 수상에 유상을 천천히 투입하며 호모 믹싱하는 통상의 화장품 제조방법에 따라 제조하였다. 메이컵 화장료 1 ~ 4까지는 본 발명 W/S 유형의 메이컵 화장료 조성물이고 메이컵 화장료 5는 종래 O/W 메이컵 화장료이다.In this embodiment, according to the conventional cosmetic preparation method of homo-mixing the oil phase into the aqueous phase after slowly dispersing and emulsifying the cosmetic composition in the emulsion and makeup cosmetic composition according to the ingredients and component ratios (wt%) shown in Table 1 below. Prepared. Makeup cosmetics 1 to 4 is a makeup cosmetic composition of the present invention W / S type, and makeup cosmetics 5 is a conventional O / W makeup cosmetics.
실험예 1: 피부보습력 및 피부자극도 조사Experimental Example 1: Investigation of skin moisturizing power and skin irritation
상기 실시예 1에서 제조한 메이컵 화장료 조성물 1 ~ 5를 패널리스트 10명을 대상으로 각각 피부에 도포한 다음 90분 후 피부 보습력 정도를 전기용량 측정방식에 의한 피부보습력 측정장치인 Corneometer CM820PC를 이용하여 측정하였다. 또한, 패널리스트 20명을 대상으로 피검자 팔뚝에 48시간 PATCH TEST하여 피부 자극도를 조사하였다. 실험결과, 메이컵 화장료 1 ~ 4까지는 피부자극이 최소 자극이였으며 메이컵 화장료 5는 보통자극이였다. 수분증가량은 메이컵 화장료 1 ~ 4까지 10.1 ~ 10.3 범위로 나타났고 메이컵 화장료 5는 6.0으로 보습력이 상당히 떨어졌다. 이를 표 2에 정리하였다.The makeup cosmetic composition 1 to 5 prepared in Example 1 was applied to the skin of 10 panelists, respectively, and after 90 minutes, the skin moisturizing power was measured using Corneometer CM820PC, a skin moisturizing power measuring device using a capacitive measuring method. It was measured by. In addition, 20 panelists were subjected to 48 hours PATCH TEST on the forearm of subjects to investigate skin irritation. As a result, skin stimulation was minimal irritation and makeup cosmetic 5 was normal irritation until makeup cosmetics 1-4. Moisture increase ranged from 10.1 to 10.3, up from makeup cosmetics 1 to 4, and makeup cosmetics 5 was significantly reduced to 6.0. This is summarized in Table 2.
실험예 2: 미백효과 조사Experimental Example 2: Investigation of Whitening Effect
상기 실시예 1에서 제조한 메이컵 화장료 조성물 1 ~ 5의 색소 침착 억제 시험을 실시하고 경시에 따른 티로시나제 활성억제효과를 측정하였다. 색소침착억제시험은 등에 인공선번 후 피부흑화도를 10으로하고 본래의 피부색을 0으로하여 육안으로 30일간 연속 도포 후 관찰한 값을 나타냈으며, 티로시나제억제효과는 각 시료당 0.5% 농도의 티로시나아제를 첨가한 후 티로시나제 효소의 감소율을 표기한 값이다. 실험결과, 표 3에 나타낸 바와 같이 메이컵 화장료 1 ~ 4까지의 티로시나제 활성 억제값은 30일 경과후 까지 큰 변화가 없는데 반해 메이컵 화장료 5는 30일 경과 후 티로시나제 활성이 거의 절반으로 감소했다. 또 색소침착억제에 있어서도 메이컵 화장료 1 ~ 4는 거의 본래의 피부색을 유지하는데 반해 메이컵 화장료 5는 흑화가 상당히 진행되었다.The pigmentation inhibition test of the makeup cosmetic compositions 1 to 5 prepared in Example 1 was carried out, and the effect of inhibiting tyrosinase activity over time was measured. The pigmentation inhibition test showed the value observed after 30 consecutive days of visual application with the skin blackening degree of 10 and the original skin color of 0 after artificial turn. The tyrosinase inhibitory effect was 0.5% concentration of tyrosinase per sample. It is the value which indicated the reduction rate of the tyrosinase enzyme after adding. As a result, as shown in Table 3, the inhibition of tyrosinase activity from the make-up cosmetics 1 to 4 did not change significantly after 30 days, whereas the makeup cosmetics 5 decreased in half by 30 days. In addition, the cosmetic make-up 1 to 4 was almost intact, while the cosmetic make-up 5 proceeded significantly in blackening.
실험예 3: 소비자 사용 시험Experimental Example 3: Consumer Use Test
상기 실시예 1에서 제조한 메이컵 화장료 조성물중 메이컵 화장료 조성물 3과 메이컵 화장료 5를 소비자 30명을 대상으로 사용감, 밀착감, 피복력 등의 항목을 총망라한 전체적인 만족도와 소비자가 직접 느끼는 미백효과를 7점 만점으로 테스트하였다. 실험결과, 표 4에 나타낸 바와 같이 미백 효과와 만족도면에서 메이컵 화장료 3이 월등이 우수하였다.Among the makeup cosmetic composition prepared in Example 1, the makeup cosmetic composition 3 and the makeup cosmetic composition 5 were used for 30 consumers. The test was carried out. As a result, as shown in Table 4, makeup cosmetics 3 was superior in terms of whitening effect and satisfaction.
상기 실험예 1~ 3 결과를 보면 알 수 있듯이, 메이컵 화장료 5과 같은 O/W 형 에멀젼에 비해 메이컵 화장료 1 ~ 4과 같은 W/S형 에멀젼으로 제형화 하였을 때 피부에 안전하였으며, 피부 보습효과 또한 높았고 특히, 미백효과는 탁월한 효과와그 효능이 지속적으로 이어졌다. 또한, 미백제의 함량은 3 % 이상에서 효과가 극대화되고 그이상에서는 더 이상의 미백효과 증진은 보이지 않아 2 ~ 4 % 함유하는 것이 적절하였다.As can be seen from the results of Experimental Examples 1 to 3, it was safer to the skin when formulated with a W / S emulsion like the makeup cosmetics 1 to 4 than the O / W emulsion like the makeup cosmetic 5 The moisturizing effect was also high, in particular, the whitening effect continued to be excellent and its efficacy. In addition, the content of the whitening agent was maximized at 3% or more, and further higher whitening effect was not seen above 2 to 4% was appropriate.
실시예 2: 본 발명 분산, 유화 메이컵 화장료 및 종래 메이컵 화장료 제조Example 2 Preparation of the Dispersion, Emulsifying Makeup Cosmetics and Conventional Makeup Cosmetics of the Present Invention
본 실시예에서는 하기 표 5에 나타낸 성분 및 성분비로 분산, 유화 메이컵 화장료 6 ~ 13을 제조하였다. 본 발명 분산, 유화 화장료 조성물에는 히아루론산, 스테아릴디메치콘, C30 ~ 45알킬메치콘 및 사이클로메치콘(D5 및 D6)을 적정량 배합하였고 종래 메이컵 화장료에는 상기 성분을 전혀 배합하지 않았다.In the present Example, the dispersion and the emulsion cosmetics 6-13 were prepared by the components and component ratios shown in Table 5 below. Hyaluronic acid, stearyldimethicone, C 30-45 alkylmethicone and cyclomethicone (D5 and D6) were blended in the dispersion and emulsion cosmetic composition of the present invention, and the above ingredients were not blended in the conventional makeup cosmetic.
실험예 1: 안정도 조사Experimental Example 1: Investigation of stability
상기 실시예 2에서 제조한 분산, 유화 메이컵 화장료 조성물 6 ~ 13의 안정도 변화를 조사하였다. 안정도 조사 방법으로써는 수적입자의 합일과 점도를 측정하였으며 수적입자의 합일은 경시에 따른 유화입자를 200배율 현미경으로 육안측정하였고 점도(브룩필드 LVT TYPE, #4, 12 RPM)는 25℃ 항온조에서 경시에 따른 변화 및 변색을 관찰하였다. 실험결과, 표 6에 나타낸 바와 같이 실리콘계 왁스인 스테아릴디메치콘, C30 ~ 45알킬디메치콘이 포함화되지않은 메이컵 화장료 12, 13은 경시에 따라 점도 하락세가 현저히 나타났고 현미경입자 또한 수적입자의 합일을 나타냈다. 또 알부틴과 비타민C 마그네슘 포스페이트에 의한 변색도 관찰되었다. 이에 반해서, 스테아릴디메치콘, C30 ~ 45알킬디메치콘이 포함된된 메이컵 화장료 6 ~10은 경시에 따른 점도 변화 및 변색이 없었으며, 메이컵 화장료 6, 9, 10, 11은 수적입자의 합일이 관찰되지 않았으나, 히아루론산과 사이클로메치콘(D6)이 함유되지 않은 메이컵 화장료 7 및 8은 수적의 합일이 다소 관찰되었다. 이는 히아루론산과 비휘발성 실리콘이 함유됨에 따라, 수적입자의 합일을 방지할 수 있고 경시에 따른 점도의 저하는 유화제의 변화로는 해결되지 않으며 스테아릴디메치콘, C30 ~ 45알킬디메치콘을 함유시켜야 해결되며 스테아릴디메치콘, C30 ~ 45알킬디메치콘의 적절한 배합조절로 점도를 자유로이 조절할 수 있음을 알 수 있었다.The change in the stability of the dispersion prepared in Example 2, emulsion cosmetic composition 6 ~ 13 was investigated. As a method of stability investigation, the union and viscosity of the soaked particles were measured, and the sum of the soaked particles was visually measured by emulsified particles with a 200x magnification over time. Changes and discolorations over time were observed. As a result, as shown in Table 6, make-up cosmetics 12 and 13 containing no silicone waxes such as stearyl dimethicone and C 30 to 45 alkyl dimethicone showed a marked drop in viscosity over time. Indicated the union of. Discoloration by arbutin and vitamin C magnesium phosphate was also observed. In contrast, the makeup cosmetics 6 to 10 containing stearyldimethicone and C 30 to 45 alkyldimethicone did not have a change in viscosity and discoloration with time, and the makeup cosmetics 6, 9, 10, and 11 were soaking particles. Although the union of was not observed, the makeup cosmetics 7 and 8 which do not contain hyaluronic acid and cyclomethicone (D6) were found to have some water droplets. As hyaluronic acid and non-volatile silicone are contained, it is possible to prevent the coalescence of soaking particles, and the decrease in viscosity with time is not solved by the change of emulsifier, and must contain stearyldimethicone and C 30 ~ 45 alkyldimethicone. Stearyl dimethicone, C 30 ~ 45 Alkyl dimethicone was found to be able to freely adjust the viscosity by appropriate mixing control.
이상 상기 실시예에서 살펴본 바와같이 알부틴 1 ~ 3중량%, 비타민 C 마그네슘 포스페이트 0.5 ~ 2중량%, 사이클로메치콘(D5) 4 ~ 17중량%, 사이클로메치콘(D6) 5 ~ 8중량%, 실리콘 유화제 1 ~ 4중량, 히아루론산 0.01 ~ 0.05중량%, C30 ~ 45알킬메치콘 0.1 ~ 4.0중량% 및 스테아릴디메치콘 1 ~ 4중량%로 구성된 본 발명 W/S 유형의 분산 유화상 메이컵 화장료 조성물은 미백기능 및 스킨케어기능이 우수하고 피부소양증이 없으며 수적 합일이나 점도저하가 없는 뛰어난 효과가 있으므로 화장품 산업상 매우 유용한 발명인 것이다.1 to 3% by weight of arbutin, 0.5 to 2% by weight of vitamin C magnesium phosphate, 4 to 17% by weight of cyclomethicone (D5), 5 to 8% by weight of cyclomethicone (D6), silicone Dispersed emulsion phase makeup cosmetic of the present invention W / S type composed of 1 to 4 wt% of emulsifier, 0.01 to 0.05 wt% of hyaluronic acid, 0.1 to 4.0 wt% of C 30 to 45 alkylmethicone and 1 to 4 wt% of stearyldimethicone The composition is a very useful invention in the cosmetic industry because it has excellent whitening function and skin care function, no skin pruritus, and excellent effect without water consolidation or viscosity reduction.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990012097A KR100311679B1 (en) | 1999-04-07 | 1999-04-07 | Water in silicon type make-up cosmetic composition with whitening function |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990012097A KR100311679B1 (en) | 1999-04-07 | 1999-04-07 | Water in silicon type make-up cosmetic composition with whitening function |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000065646A KR20000065646A (en) | 2000-11-15 |
KR100311679B1 true KR100311679B1 (en) | 2001-11-14 |
Family
ID=19578944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990012097A KR100311679B1 (en) | 1999-04-07 | 1999-04-07 | Water in silicon type make-up cosmetic composition with whitening function |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100311679B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100430606B1 (en) * | 2001-11-21 | 2004-05-10 | 주식회사 코리아나화장품 | Cosmetic Compositions Comprising Lactic Acid and Arbutin for Skin Whitening |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100375338B1 (en) * | 2001-02-09 | 2003-03-06 | 주식회사 엘지생활건강 | Solid cosmetic composition for whitening |
KR100845731B1 (en) * | 2001-12-14 | 2008-07-11 | 주식회사 코리아나화장품 | Cosmetic Compositions of Powder-type Containing Whitening Active Material |
KR100541147B1 (en) * | 2001-12-19 | 2006-01-10 | 주식회사 엘지생활건강 | Oil-free typed Cosmetic composition in the form of water-in-silicone emulsion |
KR102575780B1 (en) | 2018-10-31 | 2023-09-11 | (주)아모레퍼시픽 | Water-in-Silicon type cosmetic composition comprising film formers and sugar alcohols |
-
1999
- 1999-04-07 KR KR1019990012097A patent/KR100311679B1/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100430606B1 (en) * | 2001-11-21 | 2004-05-10 | 주식회사 코리아나화장품 | Cosmetic Compositions Comprising Lactic Acid and Arbutin for Skin Whitening |
Also Published As
Publication number | Publication date |
---|---|
KR20000065646A (en) | 2000-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101830599B1 (en) | Cosmetic compositions and methods for inhibiting melanin synthesis | |
EP3741433A1 (en) | Water-releasing cosmetic composition | |
US8158111B2 (en) | Cosmetic composition and a process for preparing said composition | |
KR20040042876A (en) | Water-in-oil emulsion cosmetic composit ion | |
KR101952529B1 (en) | Cosmetic compositions and methods for inhibiting melanin synthesis | |
JP2000229834A (en) | Cosmetic | |
KR100311679B1 (en) | Water in silicon type make-up cosmetic composition with whitening function | |
KR101590803B1 (en) | Cosmetic composition for quick whitening or improving skin tone comprising calamine | |
KR102023915B1 (en) | O/w type cosmetic composition of shape-memory phenomenon containing stabilized calamine | |
KR20070083302A (en) | Composition for inhibiting collagen degradation and promoting collagen synthesis comprising emodin | |
JPH0977638A (en) | Foundation for cosmetic | |
KR101125922B1 (en) | Cosmetic composition with low viscosity | |
KR100508978B1 (en) | Water-in-Oil Type Emulsion Foundation Cosmetic Composition Comprising Stearoyl Inulin | |
KR102066979B1 (en) | Water Stick Type Cosmetic Composition | |
CN111346028A (en) | Multi-effect repairing anti-wrinkle composition, preparation method thereof and multi-effect repairing anti-wrinkle emulsion | |
JPH06227959A (en) | Melanin formation inhibitor and skin cosmetic | |
US7455847B1 (en) | Pigmented cosmetic composition and methods related thereto | |
KR102003982B1 (en) | Cosmetic Composition of Polyol-in-Oil Formulation Comprising Metal Oxide | |
KR20200001146A (en) | Oil in Water Type Emulsified Cosmetic Composition Havung Low Stimulus And Preparation Method thereof | |
JP3939857B2 (en) | Skin cosmetics | |
KR100531726B1 (en) | Water-in-silicone make-up cosmetic composition | |
KR102513929B1 (en) | Functional comsmetics materials having composition and composition ratio for skin elasticity, Manufacturing method thereof and Comsmetics for skin care | |
KR19990009865A (en) | Water in oil type emulsion base for improving moisture supplement and lip-care compositions containing the same | |
JPH0363207A (en) | Skin cosmetic | |
KR102291076B1 (en) | Cosmetic composition containing Mentyl PCA and Ginger extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20110901 Year of fee payment: 11 |
|
LAPS | Lapse due to unpaid annual fee |